Результаты поиска

Hotspots and trends in multiple myeloma bone diseases: A bibliometric visualization analysis.

Objective: This study aims to explore the research hotspots and trends of multiple myeloma bone disease in the past 20 years by bibliometric visualization analysis. Methods: With the Web of Science Core Collection database as the data source, the relevant publications of multiple myeloma bone disease from 2002 to 2021 are retrieved. These data are analyzed using software CiteSpace 5.8.R3 and Scimago Graphica 1.0.24, together with the Online Analysis Platform of Literature Metrology. Results: A total of 6,168 published research papers, including 4668 articles and 1500 review papers, are include

Функциональное иммунное профилирование переводит динамику Т-клеток в прогнозируемые биомаркеры для иммунотерапии миеломы.

Биспектифические Т-клеточные энджеры (TCE), мишенирующие к BCMA или GPRC5D, улучшили исходы у пациентов с резидуальным/рефракторным множественным миеломой (ММ), однако до 40% пациентов являются первичными рефракторными, и предиктивные биомаркеры крайне ограничены. Чтобы решить эту неудовлетворенную клиническую потребность, мы разработали изображение-ориентированную высокопроизводительную эквивалентную вне организма пробу, используя мононуклеаты костного мозга, полученные от пациентов, подвергнутые воздействию теclistamаба или талкетамаба. Мультиплексная иммунофлуоресценция позволила количестве

2022 International Cancer Education Conference Late-Breaking Abstracts

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

АнтиBCMA и GPRC5D biotical антитела в лейкемии лейкемии плазменных клеток.

Плазменная лейкемия (PCL) является агрессивным и рискованным вариантом множественной миеломы (MM) с очень плохим прогнозом. Учитывая его редкость и агрессивность, не хватает клинических испытаний на эффективность новых методов лечения у этих пациентов. Новые иммунные подходы, такие, как антиген созревания клеток В (BCMA) и рецептор с белковым сцеплением G, семейство C, группа 5, член D (GPRC5D) - Целевые агенты, включая T-клетки химерика антигенного рецептора (CAR) и биконкретные антитела, могут играть определенную роль в лечении ПХЛ. Однако пациенты, страдающие ПХЛ, были исключены из недавних

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Data on efficacy and safety of azacitidine in acute myeloid leukemia (AML) with >30 % bone marrow (BM) blasts are limited, and the drug can only be used off-label in these patients. We previously reported on the efficacy and safety of azacitidine in 155 AML patients treated within the Austrian Azacitidine Registry (clinicaltrials.gov identifier NCT01595295). We herein update this report with a population almost twice as large (n = 302). This cohort included 172 patients with >30 % BM blasts; 93 % would have been excluded from the pivotal AZA-001 trial (which led to European Medicines Agency (E

Acute Liver Failure due to Disseminated Varicella Zoster Infection.

Acute liver failure (ALF) can be due to numerous causes and result in fatality or necessitate liver transplantation if left untreated. Possible etiologies of ALF include ischemia, venous obstruction, medications, toxins, autoimmune hepatitis, metabolic and infectious causes including hepatitis A-E, varicella-zoster virus (VZV), cytomegalovirus (CMV), herpes simplex virus (HSV), Epstein-Barr virus (EBV), and adenovirus with VZV being the most rarely reported. Pathognomonic skin lesions facilitate diagnosis of VZV hepatitis, but definitive diagnosis is secured with liver biopsy, tissue histopath

Network analysis used to investigate the interplay among somatic and psychological symptoms in patients with cancer and cancer survivors: a scoping review.

PurposePatients with cancer often experience multiple somatic and psychological symptoms. Somatic and psychological symptoms are thought to be connected and may reinforce each other. Network analysis allows examination of the interconnectedness of individual symptoms. The aim of this scoping review was to examine the current state of knowledge about the associations between somatic and psychological symptoms in patients with cancer and cancer survivors, based on network analysis.MethodsThis scoping review followed the five-stage framework of Arksey and O'Malley. The literature search was condu

Novel Therapeutics for Anthracycline Induced Cardiotoxicity.

Anthracyclines remain an essential component of the treatment of many hematologic and solid organ malignancies, but has important implications on cardiovascular disease. Anthracycline induced cardiotoxicity (AIC) ranges from asymptomatic LV dysfunction to highly morbid end- stage heart failure. As cancer survivorship improves, the detection and treatment of AIC becomes more crucial to improve patient outcomes. Current treatment modalities for AIC have been largely extrapolated from treatment of conventional heart failure, but developing effective therapies specific to AIC is an area of growing

Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study.

BackgroundIt is unclear whether sex or age modify the association of glucocorticoid (GC) use with reduced bone mineral density (BMD) in patients with rheumatoid arthritis (RA).MethodsWe studied cross-sectional data of RA patients with current or previous GC treatment in a single center cohort study (Rh-GIOP cohort). Our primary outcome was the minimum T-score (measured by DXA) of either lumbar spine, total femur, or femoral neck. Current GC dose was the main exposure; cumulative GC dose and cumulative duration of GC use were also assessed. Following a predefined statistical analysis plan, line

Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK.

BackgroundMyeloma is an incurable life-threatening hematological cancer. Recent treatment developments have seen improvements in survival; however, while patients are living longer, they are living with symptoms and treatment side effects.ObjectiveTo evaluate myeloma patients' preferences for treatment using a discrete choice experiment (DCE). This study set out to define the relative importance of key treatment attributes, characterize the risk-benefit trade-offs in patients' decision-making, and to analyze the predictive power of basic demographic factors.MethodsFour hundred seventy-five mye

FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021-2025): Pharmaceutical Use, Trends and Synthetic Approaches.

The amide functional group remains a cornerstone of medicinal chemistry, serving as an indispensable scaffold in the design of modern therapeutics. This review presents an analysis of FDA-approved drugs (small molecules and peptides with MW ®), amides form the structural backbone of peptidomimetics, enabling high-affinity binding to a viral protease. In precision oncology, as seen with adagrasib (Krazati®), the amide acts as a critical, metabolically stable linker that positions a covalent warhead for selective inhibition of a mutant kinase. This analysis underscores that amide's unique combin

Targeted synthesis of a trimethoxyphenyltetrahydropyrimidine analogue designed as a DNA intercalator: in silico, multi-spectroscopic, thermodynamic, and in vitro approaches.

Based on the rational design of DNA intercalators and Topo-II inhibitors and taking into consideration the main pharmacophoric features of doxorubicin (Dox) as a reference standard, we theoretically designed novel substituted tetrahydropyrimidine analogues (T1-35). The designed analogues (T1-35) were investigated for their inhibitory potential towards the hybrid DNA and Topo-II target receptor using molecular docking. Interestingly, the theoretically designed analogue T30 with a 3,4,5-trimethoxy phenyl side chain was found to be the superior candidate, achieving a binding score of -7.06 kcal m

Инфекционные токсичные вещества, связанные с биконкретными антителами и клетками CAR-T в множестве миеломы: систематический обзор.

Лечение с перенацеливанием клеток изменило лечение повторной/охлажденной множественной миэломы (RRMM), но связано со значительным риском инфицирования. Мы систематически анализировали инфекционные заболевания после терапии Т-клеток CAR и биконкретных антител (BSAbs) с уделением особого внимания частотности, времени, патогенам, факторам риска и профилактике. Следуя руководящим принципам PRISMA, мы обыскали Паббмеда до мая. 22, 2026, и включает исследования, содержащие информацию о инфекционных результатах у пациентов, проходящих курс лечения с помощью клеток CAR-T или BsAbs. Всего 123 Был прове

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.

Determining the etiologies of left ventricular hypertrophy (LVH) can be challenging due to the similarities of the different manifestations in clinical presentation and morphological features. Depending on the underlying cause, not only left ventricular mass but also left ventricular cavity size, or both, may increase. Patients with LVH remain asymptomatic for a few years, but disease progression will lead to the development of systolic or diastolic dysfunction and end-stage heart failure. As hypertrophied cardiac muscle disrupts normal conduction, LVH predisposes to arrhythmias. Distinguishin

Регулирование глюкозы как движущая сила аутоиммунной мимикрии, воспаления и психиатрических Симптомов: обзор наизусть.

Происхождение глицемии влияет на широкий спектр психических и физиологических симптомов. Многие психические заболевания связаны с плохим регулированием глюкозы. Антиядерные антитела (АНА), широко используемые для выявления аутоиммунных заболеваний, могут иногда отражать переходную метаболическую активацию иммунной системы, а не хроническую патологию. Имеющиеся данные свидетельствуют о том, что регулирование глюкозы, включая глицемическую изменчивость, реактивную гипогликемию и постприндиальные шипы, может вызвать системное воспаление, нейропсихиатрические симптомы и временное производство авто

Представление результатов анализа диабетических осложнений с головы до ног: всеобъемлющий радиологический обзор.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Немногодействующий клеточный ассоциированный гематотоксичный с вторичным миэлофиброзом после Идекабтаген-Виклеукеля для множественной миеломы, полностью обработанный аутентичным гематопоэтическим сетком.

Panktopenia в сочетании с химериковой антигенной рецепторной клеткой T (CAR-T) называется иммунной гематопоиетической токсичностью (ICAHT), которая часто устойчива и противодействует поддержке. Мы сообщаем о случае 52-year-old Человек с множественной миеломой, который развил серьёзный ИКАХТ с вторичным миэлофиброзом (SMF) после введения идекабатагена-виклеукаля, который был полностью усовершенствован за счет аутологического гематопоиетического усиления стволовых клеток. В данном случае основное внимание уделяется СМФ как редким, но осторожным осложнениям CAR-T-терапии, что подчеркивает важност

Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.

BackgroundVery little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised causing them to be more susceptible to a host of infections. As a precautionary measure, many clinical studies halted enrollment during the initial surge of the global Novel Coronavirus Disease (COVID-19) pandemic. In this case report, we detail the successful treatment of a relapsed and refractory multiple myeloma (MM) patient treated with an anti-B cell maturation antigen (BCMA) chimeric antigen receptor

Paraneoplastic Endocrine Changes in Gastrointestinal Tumors: A Clinical and Mechanistic Review.

Paraneoplastic endocrine syndromes (PESs) are hormonal disturbances associated with malignancies that result from tumor-related production of hormone-like substances, immune-mediated mechanisms, or dysregulated signaling pathways. While they are well recognized in lung and neuroendocrine cancers, their relevance in gastrointestinal tumors remains less clearly defined. This narrative review synthesizes current knowledge on paraneoplastic endocrine manifestations in gastrointestinal malignancies, based on a structured search of the literature in major databases, including PubMed, Scopus, and Web

Совпадение в полном тексте источника
… Glucocorticoids reliably suppress “big” IGF-2 and restore euglycemia as a bridge therapy [ 33 , 48 , 49 ]. Imatinib resolves NICTH in GIST by targeting the upstream oncogenic pathway [ 50 ]. Tumor resection is the only curative intervention [ 4 ]. …

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges.

Chimeric antigen receptor T (CAR-T) cell therapy represents a major breakthrough in cancer treatment, and it has achieved unprecedented success in hematological malignancies, especially in relapsed/refractory (R/R) B cell malignancies. At present, CD19 and BCMA are the most common targets in CAR-T cell therapy, and numerous novel therapeutic targets are being explored. However, the adverse events related to CAR-T cell therapy might be serious or even life-threatening, such as cytokine release syndrome (CRS), CAR-T-cell-related encephalopathy syndrome (CRES), infections, cytopenia, and CRS-rela